deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06646653

Feasibility Clinical Study of the Alma System in Treating Primary Postpartum Hemorrhage

Sponsor: ResQ Medical Ltd

Interventions Alma System
Updated 1 time since 2024 Last updated: Oct 15, 2024 Started: Apr 14, 2024 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates PPH and Postpartum Haemorrhage (PPH) and is currently actively recruiting participants. ResQ Medical Ltd leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2024 – present · 20 months · monthly snapshotRecruiting

Change History

1 version recorded
Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ResQ Medical Ltd
Data source: ResQ Medical Ltd

For direct contact, visit the study record on ClinicalTrials.gov .